Cargando…
TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression
Multidrug resistance (MDR) is the major obstruction in the successful treatment of breast cancer (BCa). The elucidation of molecular events that confer chemoresistance of BCa is of major therapeutic importance. Several studies have elucidated the correlation of TRPS1 and BCa. Here we focused on the...
Autores principales: | Hu, Jing, Zhang, Hui, Liu, Long, Han, Bo, Zhou, Gengyin, Su, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338551/ https://www.ncbi.nlm.nih.gov/pubmed/32695669 http://dx.doi.org/10.3389/fonc.2020.00934 |
Ejemplares similares
-
TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12
por: Hu, Jing, et al.
Publicado: (2018) -
Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer
por: Ni, Wenting, et al.
Publicado: (2021) -
Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014) -
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators
por: Dei, Silvia, et al.
Publicado: (2019) -
Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression
por: Liu, Hongxiang, et al.
Publicado: (2018)